Olga Tsachouridou - Infectious Diseases

Author Information

Olga Tsachouridou is affiliated with the 1st Internal Medicine Department, Infectious Diseases Division at the Medical School of Aristotle University of Thessaloniki, located at 1, Stilponos Kyriakidi Str, 54636, Thessaloniki, Greece. Her research primarily focuses on infectious diseases, with a significant emphasis on HIV and COVID-19.

Research Contributions

Olga Tsachouridou has made substantial contributions to the understanding of infectious diseases, particularly HIV and COVID-19. Her research delves into various aspects such as the quality of life of people living with HIV, the origin and transmission rates of major HIV-1 clusters in Greece, and the effect of pharmacological interventions on bone metabolism in HIV patients. She has also explored the impact of B cells and functional polymorphisms in COVID-19, as well as the role of anakinra in preventing respiratory failure and reducing mortality in COVID-19 patients.

Aliases

Olga Tsachouridou is also known by the aliases O Tsachouridou and O. Tsachouridou.

Publication and Citation Metrics

Metric	Value
Citation Count	448
H-index	10
Paper Count	51

Publications:

An exploration of the quality of life of people living with HIV in Greece: Challenges and opportunities

DOI: 10.1371/journal.pone.0266962

Year: 2022

Dating the Origin and Estimating the Transmission Rates of the Major HIV-1 Clusters in Greece: Evidence about the Earliest Subtype A1 Epidemic in Europe

DOI: 10.3390/v14010101

Year: 2022

The effect of pharmacological cessation and restoration of menstrual cycle on bone metabolism in premenopausal women with endometriosis.

DOI: 10.1016/j.bone.2022.116354

Year: 2022

Circulating microRNAs Related to Bone Metabolism in HIV-Associated Bone Loss

DOI: 10.3390/biomedicines9040443

Year: 2021

B cells and COVID-19: Lessons from agammaglobulinemia patients and the study of functional B cell polymorphisms.

DOI: 10.18176/jiaci.0726

Year: 2021

An open label trial of anakinra to prevent respiratory failure in COVID-19

DOI: 10.7554/eLife.66125

Year: 2021

Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients

DOI: 10.1016/j.bonr.2021.101128

Year: 2021

Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

DOI: 10.1016/S2665-9913(21)00216-2

Year: 2021

Author response: An open label trial of anakinra to prevent respiratory failure in COVID-19

DOI: 10.7554/ELIFE.66125.SA2

Year: 2021

Integration of heparin-binding protein and interleukin-6 in the early prediction of respiratory failure and mortality in pneumonia by SARS-CoV-2 (COVID-19)

DOI: 10.1007/s10096-020-04145-7

Year: 2021

What Are Some of WHO’s Recent Initiatives in Infectious Disease Control?

How Effective Are Masks?

Which Diseases Are Transmitted by Aedes Aegypti?

What are the Challenges and Risks?

What Role Does the FDA Play in Diagnostic Testing?

When Should Antipyretics be Used?

Are There Different Types of Condoms?

What is the Future of Infectious Disease Education?

How Can HSV Be Prevented?

What Are Some Common Resistant Bacteria?

Partnered Content Networks

Relevant Topics